Acquisition

June 22, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Dear Sir/ Madam, Trading Symbol: ZOTA Sub: Intimation of Acquisition of 20,00,000 equity shares of M/s KMHP Ventures Limited, Wholly Owned Subsidiary of the Company, by way of subscription to the right issue. Ref.: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, Zota Health Care Limited (the “Company”), would like to inform you that the Company has acquired 20,00,000 equity shares of M/s KMHP Ventures Limited (“KMHP”), Wholly Owned Subsidiary of the Company, by way of subscription to the right issue. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated 13th July, 2023 are annexed herewith as (Annexure-I). This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Annexure-I Particulars Details Name of the target entity, details in brief such as size, i. Name of the Target Entity: KMHP Ventures Limited turnover etc. (‘KMHP’) ii. Business of the Target Entity: KMHP has an object of doing business in the pharmaceutical segment and planning to rollout retail stores under the brand name of “Ugo Generic” which will operate in both Business to Business (B2B) and Business to Consumer (B2C) model. iii. Financial details: as per the audited financial statements for the Financial Year 2025-26, the turnover of KMHP was Rs. NIL and the total paid up share capital was Rs. 10 Lakhs. Whether the acquisition would fall within related party No, the acquisition does not fall within the ambit of related transaction(s) and whether the promoter/ promoter group/ party transactions. The promoter/ promoter group/ group group companies have any interest in the entity being companies do not have any interest in KMHP and the said acquired? If yes, nature of interest and details thereof and transaction is done at arm’s length basis. whether the same is done at “arm’s length” Industry to which the entity being acquired belongs Pharmaceutical Objects and effects of acquisition (including but not limited The Company has made investment in KMHP as a part of to, disclosure of reasons for acquisition of target entity, if its strategic investment; wherein KMHP is planning to rollout business is outside the main line of business of the listed store chain under the brand name of “Ugo Generic” which entity); will operate in both Business to Business (B2B) and Business to Consumer (B2C) model and offer high quality generic medicines on a PAN India basis through its owned stores as well as ~12.5 lakhs retail pharmacies to be onboarded under Ugo Generic and working capital requirements of KMHP. Post to this acquisition, KMHP continues to remain as the Wholly-owned Subsidiary of the Company. Brief details of any governmental or regulatory approvals N.A. required for the acquisition Indicative time period for completion of the acquisition On June 22, 2026, the Company has acquired the said 20,00,000 equity shares of KMHP by subscription to the right issue. Nature of consideration - whether cash consideration or Cash consideration by way of acquisition of Equity Shares. share swap and details of the same; Cost of acquisition or the price at which the shares are Cost of acquisition for subscription of 20,00,000 Equity acquired Shares offered on right basis is Rs. 10.00/- per equity share aggregating to Rs. 2,00,00,000.00/-. Percentage of shareholding / control acquired and / or The Company has acquired 20,00,000 equity shares of number of shares acquired KMHP. Post to this acquisition, KMHP continues to remain as the Wholly Owned Subsidiary of the Company. Brief background about the entity acquired in terms of KMHP was incorporated on January 13, 2026, domiciled in products/line of business acquired, date of incorporation, India; engaged in the business of pharmaceutical segment history of last 3 years turnover, country in which the acquired and planning to rollout retail stores under the brand name entity has presence and any other significant information (in of “Ugo Generic” which will operate in both Business to brief) Business (B2B) and Business to Consumer (B2C) model and offer high quality generic medicines on a PAN India basis through its owned stores as well as ~12.5 lakhs retail pharmacies to be onboarded under Ugo Generic. During last three financial years, the details of turnover of KMHP were as follows: FY 2025-26: Rs. NIL FY 2024-25: N.A. FY 2023-24: N.A.